February 23, 2018 9:54 AM ET

Capital Markets

Company Overview of Paragon Pharmaceuticals, LLC

Executive Profile

Jeffrey S. Aronin

Chairman and Chief Executive Officer, Paragon Pharmaceuticals, LLC
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 organization across 8 different industries.

See Board Relationships
49--

Background

Mr. Jeffrey S. Aronin, also known as Jeff, has been the Chief Executive Officer of Paragon Pharmaceuticals, LLC since January 2010. Mr. Aronin founded Paragon Pharmaceuticals in December 2009. He served as the Chief Executive Officer of Marathon Pharmaceuticals, LLC until May 2017. He also served as the President at Marathon Pharmaceuticals, LLC. He serves as a Special Advisor at Merrick Ventures, LLC. He is the founder of MATTER. He founded Lundbeck Inc in 2000 and ...

Corporate Headquarters

1033 Skokie Boulevard
Northbrook, Illinois 60062

United States

Phone: 224-515-3500
Fax: 224-515-3510

Board Members Memberships

Director
Director
Director
Director
Chairman
Non-Executive Chairman
2007-Present
Director
2010-Present
Chairman and Chief Executive Officer

Education

MBA
DePaul University
BS
Northern Illinois University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Paragon Pharmaceuticals, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.